Evidence map›Paper›PMID 23461860›Full record

ArticleEuropean journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V2014

Microneedle/nanoencapsulation-mediated transdermal delivery: mechanistic insights.

Yasmine A Gomaa, Martin J Garland, Fiona J McInnes, Ryan F Donnelly, Labiba K El-Khordagui, Clive G Wilson

Abstract read
In one paragraph

Article in European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Design, formulation and evaluation of novel dissolving microarray patches containing a long-acting rilpivirine nanosuspension.Journal of controlled release : official journal of the Controlled Release Society · 2018
    Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yasmine A GomaaStrathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS), University of Strathclyde, Scotland, UK; Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt.
Martin J GarlandSchool of Pharmacy, Queen's University of Belfast, Northern Ireland, UK.
Fiona J McInnesStrathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS), University of Strathclyde, Scotland, UK.
Ryan F DonnellySchool of Pharmacy, Queen's University of Belfast, Northern Ireland, UK.
Labiba K El-KhordaguiDepartment of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt. Electronic address: lakhalil@alexpharmacy.edu.eg.
Clive G WilsonStrathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS), University of Strathclyde, Scotland, UK.

Funding

Biotechnology and Biological Sciences Research Council BB/E020534/1Biotechnology and Biological Sciences Research Council BBE020534/1
6 · The paper itself

Abstract

A systematic study was undertaken to gain more insight into the mechanism of transdermal delivery of nanoencapsulated model dyes across microneedle (MN)-treated skin, a complex process not yet explored. Rhodamine B (Rh B) and fluorescein isothiocyanate (FITC) as model hydrophilic and hydrophobic small/medium-size molecules, respectively, were encapsulated in poly lactic-co-glycolic acid (PLGA) nanoparticles (NPs) and delivered through full thickness porcine skin pretreated with MN array. Permeation through MN-treated skin was affected by physicochemical characteristics of NPs and the encapsulated dyes. Dye flux was enhanced by smaller particle size, hydrophilicity, and negative zeta potential of NPs. Regarding encapsulated dyes, solubility at physiological pH and potential interaction with skin proteins proved to outweigh molecular weight as determinants of skin permeation. Data were verified using confocal laser scanning microscopy imaging. Findings coupled with the literature data are supportive of a mechanism involving influx of NPs, particularly of smaller size, deep into MN-created channels, generating depot dye-rich reservoirs. Molecular diffusion of the released dye across viable skin layers proceeds at a rate determined by its molecular characteristics. Data obtained provide mechanistic information of importance to the development of formulation strategies for more effective intradermal and transdermal MN-mediated delivery of nanoencapsulated therapeutic agents.

Indexed as

Administration, CutaneousAnimalsDrug Delivery SystemsFluoresceinHydrophobic and Hydrophilic InteractionsIsothiocyanatesLactic AcidMicroinjectionsNanoparticlesNeedlesParticle SizePermeabilityPolyestersPolymersRhodaminesSkinFluoresceinIsothiocyanatesisothiocyanic acidLactic AcidPolyesterspoly(lactide)Polymersrhodamine BRhodaminesConfocal laser scanning microscopyFluorescein isothicoyanateMicroneedlesPLGA nanoparticlesRhodamine BSkin permeationTransdermal delivery

Identifiers

PMID23461860
PMCPMC4074889

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.